AGAP2
Basic information
Region (hg38): 12:57723761-57742157
Previous symbols: [ "CENTG1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AGAP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 56 | 61 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 56 | 10 | 3 |
Variants in AGAP2
This is a list of pathogenic ClinVar variants found in the AGAP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-57726635-T-C | not specified | Uncertain significance (May 10, 2022) | ||
12-57726649-G-A | not specified | Uncertain significance (Mar 27, 2023) | ||
12-57726658-G-C | not specified | Uncertain significance (Dec 21, 2022) | ||
12-57726761-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
12-57727000-C-T | not specified | Uncertain significance (Dec 27, 2022) | ||
12-57727002-T-C | not specified | Uncertain significance (Jun 21, 2022) | ||
12-57727022-G-A | AGAP2-related disorder | Likely benign (Mar 29, 2019) | ||
12-57727112-G-C | not specified | Uncertain significance (Aug 11, 2022) | ||
12-57727149-A-G | not specified | Uncertain significance (Apr 07, 2023) | ||
12-57727170-A-C | not specified | Uncertain significance (Jan 24, 2023) | ||
12-57727427-C-A | not specified | Uncertain significance (Sep 16, 2021) | ||
12-57727471-T-A | not specified | Uncertain significance (Aug 31, 2022) | ||
12-57727489-C-A | AGAP2-related disorder | Uncertain significance (Apr 29, 2024) | ||
12-57727491-A-T | AGAP2-related disorder | Likely benign (Apr 29, 2024) | ||
12-57727704-A-G | not specified | Likely benign (Jan 29, 2024) | ||
12-57727716-T-A | not specified | Uncertain significance (Apr 25, 2023) | ||
12-57727974-A-G | not specified | Uncertain significance (Feb 13, 2024) | ||
12-57728061-A-G | AGAP2-related disorder | Uncertain significance (Oct 07, 2022) | ||
12-57729733-A-G | AGAP2-related disorder | Likely benign (Mar 25, 2019) | ||
12-57730531-T-G | not specified | Uncertain significance (Feb 27, 2023) | ||
12-57730577-G-A | AGAP2-related disorder | Likely benign (Oct 28, 2019) | ||
12-57730609-T-C | not specified | Uncertain significance (Feb 22, 2023) | ||
12-57730883-C-T | not specified | Uncertain significance (Feb 17, 2022) | ||
12-57730932-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
12-57731596-C-A | not specified | Uncertain significance (Jan 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AGAP2 | protein_coding | protein_coding | ENST00000547588 | 19 | 16961 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00184 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.39 | 401 | 643 | 0.624 | 0.0000369 | 7467 |
Missense in Polyphen | 129 | 257.51 | 0.50096 | 2807 | ||
Synonymous | 1.04 | 252 | 274 | 0.920 | 0.0000158 | 2642 |
Loss of Function | 5.58 | 7 | 49.3 | 0.142 | 0.00000292 | 520 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.000206 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase-activating protein (GAP) for ARF1 and ARF5, which also shows strong GTPase activity. Isoform 1 participates in the prevention of neuronal apoptosis by enhancing PI3 kinase activity. It aids the coupling of metabotropic glutamate receptor 1 (GRM1) to cytoplasmic PI3 kinase by interacting with Homer scaffolding proteins, and also seems to mediate anti-apoptotic effects of NGF by activating nuclear PI3 kinase. Isoform 2 does not stimulate PI3 kinase but may protect cells from apoptosis by stimulating Akt. It also regulates the adapter protein 1 (AP-1)-dependent trafficking of proteins in the endosomal system. It seems to be oncogenic. It is overexpressed in cancer cells, prevents apoptosis and promotes cancer cell invasion. {ECO:0000269|PubMed:12640130, ECO:0000269|PubMed:14761976, ECO:0000269|PubMed:15118108, ECO:0000269|PubMed:16079295}.;
- Pathway
- Endocytosis - Homo sapiens (human);FoxO signaling pathway - Homo sapiens (human);Prolactin Signaling Pathway;JAK-STAT;Developmental Biology;Netrin-1 signaling;Axon guidance;Netrin-mediated signaling events;Trk receptor signaling mediated by PI3K and PLC-gamma
(Consensus)
Recessive Scores
- pRec
- 0.233
Intolerance Scores
- loftool
- 0.494
- rvis_EVS
- -0.18
- rvis_percentile_EVS
- 40.56
Haploinsufficiency Scores
- pHI
- 0.817
- hipred
- Y
- hipred_score
- 0.669
- ghis
- 0.599
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.530
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Agap2
- Phenotype
- liver/biliary system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein transport;negative regulation of protein catabolic process;negative regulation of neuron apoptotic process;positive regulation of GTPase activity;positive regulation of 1-phosphatidylinositol-3-kinase activity
- Cellular component
- nucleus;nucleolus;cytoplasm;mitochondrion;membrane;extracellular exosome
- Molecular function
- GTPase activity;GTPase activator activity;protein binding;GTP binding;metal ion binding